Marvin S. Yu, Ph.D., MS2 Array CEO & Co-Founder
Dr. Yu brings both large pharmaceutical company and small chemical technology company experience to MS2 Array. Prior to founding MS2 Array he served as Vice-President of Technology at Fluorous Technologies, Inc.(FTI) where he conceived and developed the MS2 Array technology concept along with developing other fundamental concepts of fluorous partitioning. Prior to joining FTI he was a Team Manager at GlaxoSmithKline. He has a proven track record of scientific and business accomplishments including being principal investigator on 4 NIH SBIR grants.
Advisory Board
Philip E. Yeske, Ph.D. MS2 Array Co-Founder
Dr. Yeske provides both technical and entrepreneurial experience to MS2 Array as Co-Founder and Advisory Board member. He is currently the Science & Alliance Officer of the United Mitochondrial Disease Foundation responsible for managing all scientific and business development efforts of the foundation related to the development of treatments and cures for mitochondrial disorders. Prior experience includes serving as President & CEO of Fluorous Technologies, Inc. and 10 years at Bayer Corporation where he progressed from basic research to global account management.
Angela Koehler, Ph.D.
Dr. Koehler is currently Associate Professor of Biochemical Engineering at the Koch Institute at MIT. She is also a Founding Member of the MIT Center for Precision Cancer Medicine and is scientific founder of Kronos Bio, Inc. Honors include being named a a Genome Technology Young Investigator and a Merkin Institute Fellow. Dr. Koehler provides MS2 Array with valuable scientific expertise in array technologies, drug discovery, and current trends within the pharmaceutical and biotechnology sectors in addition to her knowledge and network within the Boston life sciences community.